2 completed, 2 terminated, 1 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 2, Completed 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow RIST4721: new trials by email Literature Review of RIST4721 trials Research Report on RIST4721
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate RIST4721 in Familial Mediterranean Fever (FMF) RIST4721 - Familial Mediterranean Fever | Phase 2 | Withdrawn | Aristea Therapeutics, Inc. | 2022-09-13 | 2023-02-13 | |
| A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS) RIST4721, Placebo - Hidradenitis Suppurativa | Phase 2 | Terminated | Aristea Therapeutics, Inc. | 25 | 2022-07-18 | 2023-06-13 |
| A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) RIST4721, Placebo - Palmoplantar Pustulosis | Phase 2 | Terminated | Aristea Therapeutics, Inc. | 79 | 2022-01-05 | 2023-06-29 |
| A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model RIST4721, Placebo - Inflammatory Response | Phase 1 | Completed | Aristea Therapeutics, Inc. | 32 | 2019-07-25 | 2020-06-29 |
| A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) RIST4721, Placebo - Palmoplantar Pustulosis | Phase 2 | Completed | Aristea Therapeutics, Inc. | 35 | 2019-02-13 | 2022-04-05 |
Psoriasis (2) · Familial Mediterranean Fever (1) · Hidradenitis Suppurativa (1)
Aristea Therapeutics, Inc. (5)
Canada (3) · Germany (2) · United Kingdom (2) · United States (2) · Czechia (1) · Hungary (1) · Poland (1)